Genuity Capital Markets
http://www.genuitycm.com/Genuity Capital Markets is a financial services firm providing investment banking, institutional sales and trading, and equity research to its corporate clients. The firm uses a simple Buy, Hold and Sell rating system in its research analysis.
View Older Stories View More Recent Stories
-
Canaccord Genuity Reiterates a 'Buy' on Sun Life Financial (SLF); Investor Day Highlights
-
Canaccord Genuity Maintains a 'Buy' on Onyx Pharmaceuticals (ONXX); C-MIB ASH Presentation Could Fall Short on Details
-
Canaccord Genuity maintains a 'Buy' on Nuance Communications (NUAN); Modest Q4 Upside, Promising F2011 Outlook
-
Canaccord Genuity Reiterates a 'Buy' on Analog Devices (ADI); Resilient Through Correction
-
UPDATE - Canaccord Genuity Initiates Coverage on Mitel Networks (MITL) with a Hold; Upside, But Challenges Loom
-
Canaccord Genuity Upgrades Mag Silver Corp. (MVG) to Buy; Celebrating Cinco de Mayo
-
Canaccord Genuity Upgrades Gammon Gold (GRS) to Buy; Silver Leverage Improves Outlook
-
Canaccord Genuity Morning Coffee on Ireland Aid Package: Timber
-
Canaccord Genuity Morning Coffee on SanDisk (SNDK): Jumping Jack Flash
-
Canaccord Genuity Morning Coffee on Regeneron Pharma (REGN): Stick a Needle in My Eye
-
Canaccord Genuity Morning Coffee on Netflix (NFLX): Full Stream Ahead
-
Canaccord Genuity Morning Coffee on Hewlett-Packard (HPQ): Nice Beats
-
Canaccord Genuity Morning Coffee on Green Mtn. Coffee (GMCR): A Mild Roast, It Turns Out
-
Canaccord Genuity Upgrades Mag Silver Corp. (MVG) to Buy
-
Canaccord Genuity Starts Mitel (MITL) at Hold
-
Canaccord Genuity Maintains a 'Sell' on Seattle Genetics (SGEN); ASH Preview: High Expectations Going Into Data Presentations
-
Canaccord Genuity Reiterates a 'Buy' on NxStage Medical (NXTM); Hemodialysis Frequency Data Positive
-
Canaccord Genuity Maintains a 'Buy' on Amarin (AMRN); Additional JELIS Sub-analysis Supports Promise of AMR101
-
Canaccord Genuity Reiterates a 'Buy' on Green Mountain Coffee Roasters (GMCR); Accounting Issues Resolved, Focus Returns to the Strong Fundamentals
-
Canaccord Genuity Maintains a 'Hold' on Manulife Financial (MFC); Investor Day
-
Canaccord Genuity Reiterates a 'Buy' on Northern Oil and Gas (NOG); Accelerating Acquisition and Development Program
-
Canaccord Genuity Upgrades Triangle Petroleum (TPLM) to Buy
-
Canaccord Genuity reiterates a 'Buy' rating on Quidel Corp. (QDEL); Flu Season Likely to Come Late
-
Canaccord Genuity maintains a 'Buy' rating on Optimer Pharmaceuticals (OPTR); Mid-2011 Fidaxo Approvals Expected; Robust Launch Prep Underway
-
Canaccord Genuity Maintains a 'Buy' Telvent GIT (TVLT); Margins Show Real Momentum
-
Canaccord Genuity Maintains a 'Buy' on Canadian Solar (CSIQ); Strong Q3 Report and Guidance
-
Canaccord Genuity Maintains a 'Hold' on eDiets (DIET); Progress Continues as Q3 Is In Line
-
Canaccord Genuity Maintains a 'Buy' on Juniper Networks (JNPR); Another Pony in the Video Stable
-
Canaccord Genuity Maintains a 'Hold' on salesforce.com (CRM); Waiting For Correction To Give Us A Better Entry Point
-
Canaccord Genuity Reiterates a 'Buy' on Intuit (INTU); Steady Ahead for Earnings and Shares
-
Canaccord Genuity Maintains a 'Buy' on Autodesk (ADSK); Our Top Large-Cap GARP Stock
-
Canaccord Genuity Reiterates a 'Buy' on Helmerich & Payne (HP); Nice Q4 Beat and New Rig Adds
-
Canaccord Genuity Morning Coffee on NetApp (NTAP): Do They Make a Pill for That?
-
Canaccord Genuity Morning Coffee on General Motors (GM): Did You Hear The News?
-
Canaccord Genuity Morning Coffee on Dendreon (DNDN): Better Than Maximally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
-
Canaccord Genuity Morning Coffee on Dollar Tree (DLTR): Lush
-
Canaccord Genuity Morning Coffee on Activision Blizzard (ATVI): Back in Black Ops
-
Analysts Remain Bullish on Dendreon (DNDN) Following Positive MEDCAC Review
-
Q3 Preview: Salesforce.com (CRM) Historically Beats Q3 Views by 2%, Shaping Up for the Same This Quarter
-
Traders Buying NetApp (NTAP) Shares Following Yesterday's Knee-Jerk Move Lower; Stock Added to Deutsche Bank's 'Short-Term Buy' List Today
-
Canaccord Genuity Reiterates a 'Buy' on Dendreon (DNDN); MEDCAC Weighs In: Data Supports Provenge Utility
-
Canaccord Genuity Maintains a 'Buy' on TransCanada (TRP); Investor Day Details on Mainline Toll Address Investor Concerns
-
Notable Analyst Rating Changes 11/18: NTAP, ATI, STP, PERY Upgraded; ALU, ABT, F, CMG Downgraded
-
Canaccord Genuity maintains a 'Hold' on Spreadtrum Communications (SPRD); Raises PT on Strong Q3/10 Results and Q4/10 Guidance
-
Canaccord Genuity Upgrades NetApp (NTAP) to Buy; Opportunity Knocks
-
Canaccord Genuity Maintains a 'Hold' on GMX Resources (GMXR); Reducing Rig Commitments, Focused on 2011 Cost Control
-
Canaccord Genuity Upgrades NetApp (NTAP) to Buy, Price Target $56
-
After-Hours Movers 11/17: DRYS, DNDN, LTD, SPRD Higher; APWR, HEAT, LGCY, NXTM, PETM Lower
-
NxStage Medical (NXTM) Announces 3.2M Common Sale
-
Canaccord Genuity Reiterates a 'Sell' Rating on RINO International (RINO); Company Puts Up No Defense
